Skip to main content
TipRanks
Go Ultimate75% OFF

Evotec AG (EVO) Stock Price & Analysis

238 Followers

EVO Stock Chart & Stats

$1.58-$0.08(-4.82%)
At close: 4:00 PM EST
$1.5$1.75$2Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$1.57 - $1.63
52-Week Range
$1.33 - $3.87
Previous Close
$1.66
Volume
N/A
Average Volume (3M)
97.76K
Market Cap
$580.81M
Enterprise Value
$700.21M
Total Cash (Recent Filing)
$418.48M
Total Debt (Recent Filing)
$0
Price to Earnings (P/E)
―
Beta
1.10
Next Earnings
Apr 14, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

D&PD Commercial Momentum

Strong D&PD sales growth, rising inbound leads, faster proposal turnaround, and customer-base expansion indicate improving commercial traction. These trends can support more reliable utilization of Evotec’s discovery platforms and strengthen its position with pharmaceutical and biotechnology partners over the next several quarters.

Vertex Commercial Manufacturing Partnership

Vertex’s selection provides a high-quality commercial manufacturing anchor for JEB and supports planned capacity expansion. A customer commitment at commercial scale can improve facility utilization, validate Evotec’s biologics platform, and create a foundation for additional manufacturing and partnership opportunities.

Horizon Cost Transformation

Savings delivered ahead of plan, alongside workforce and site-footprint actions, should create a more efficient cost base. If execution continues, Horizon can reduce operating drag, improve cash discipline, and help the business convert revenue growth and platform activity into stronger margins over the medium term.

Bears Say

Persistent Losses And Cash Burn

Evotec remains materially loss-making and consumes cash despite revenue growth and improved gross margin. Negative operating and free cash flow reduce internal funding capacity, increase reliance on liquidity or external financing, and constrain the company’s ability to invest while pursuing its transformation.

Declining Nine-month Revenue And EBITDA

The nine-month contraction shows that sales conversion, project timing, and delayed JEB activity are still weighing on realized performance. Continued volatility makes earnings less predictable and could delay the benefits of pipeline growth, partnerships, and cost reductions if revenue ramps remain uneven.

Liquidity Deterioration

A substantial quarterly liquidity decline is concerning while the company remains loss-making and cash-flow negative. Lower liquidity reduces financial flexibility, limits tolerance for further execution setbacks, and may force management to prioritize preservation of cash over capacity expansion or other strategic investments.

Evotec AG News

EVO FAQ

What was Evotec AG’s price range in the past 12 months?
Evotec AG lowest stock price was $1.33 and its highest was $3.87 in the past 12 months.
What is Evotec AG’s market cap?
Evotec AG’s market cap is $580.81M.
When is Evotec AG’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Evotec AG’s earnings last quarter?
Evotec AG released its earnings results on Nov 05, 2026. The company reported -$0.084 earnings per share for the quarter, beating the consensus estimate of -$0.178 by $0.094.
Is Evotec AG overvalued?
According to Wall Street analysts Evotec AG’s price is currently Undervalued.
Does Evotec AG pay dividends?
Evotec AG pays a monthly dividend of $0.072 which represents an annual dividend yield of ―. See more information on Evotec AG dividends here
What is Evotec AG’s EPS estimate?
Evotec AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evotec AG have?
Evotec AG has 355,819,950 shares outstanding.
What happened to Evotec AG’s price movement after its last earnings report?
Evotec AG reported an EPS of -$0.084 in its last earnings report, beating expectations of -$0.178. Following the earnings report the stock price went up 13.057%.
Which hedge fund is a major shareholder of Evotec AG?
Hedge funds hold Evotec AG shares: the largest hedge-fund position in Evotec AG is 71,888,487 shares, and hedge funds decreased their holdings by 6.3K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology